Weak economic data and inflation slowing down over the last few weeks have raised hope among investors that the Fed might have finally concluded its rate-hike cycle. The Fed’s favorite inflation metric, PCE, also showed signs of slowing down last week, and third-quarter GDP was revised upward to lift investor mood. It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood.